(Circulation. 1995;92:2617-2621.)
© 1995 American Heart Association, Inc.
Articles |
Magnesium Sulfate Reduces Myocardial Infarct Size When Administered Before but Not After Coronary Reperfusion in a Canine Model
From the University of Wisconsin Medical School, Milwaukee Clinical Campus, Sinai Samaritan Medical Center, and Cardiology Associates of the UP, PC, Marquette (Mich) Medical/Dental Center (N.E.G.).
Correspondence to Carl W. Christensen, PhD, Sinai Samaritan Medical Center, PO Box 342 W419, Milwaukee, WI 53201-0342.
Background The role of magnesium in treating acute myocardial infarction (AMI) has been controversial. Several small clinical trials indicate that magnesium may have a role in treating AMI early, whereas the other results suggest that magnesium is of questionable benefit.
Methods and Results We looked at the effect of magnesium on infarct size (IS) when given during a coronary occlusion and after reperfusion. Magnesium sulfate (6-mEq bolus plus 2 mEq/h for 5 hours) was given at 15 or 45 minutes of coronary occlusion or 15 minutes of reperfusion. The left anterior descending coronary artery was occluded for 90 minutes, followed by 300 minutes of reperfusion. IS to area at risk (IS/AR) was measured by planimetry after triphenyltetrazolium chloride staining. Collateral myocardial blood flow was measured with radioactive microspheres. The IS/AR ratio in the control group was 52.3±19.6% compared with 20.5±11.7% and 21.3±6.5% at 15 and 45 minutes of occlusion, respectively (P<.05). There were no significant differences in the reduction in IS at 15 and 45 minutes of occlusion. Although there was a reduction in the IS when magnesium was administered during reperfusion (38.2±13.4%), it was not statistically significant. There was no significant difference in the AR relative to the total left ventricular weight between the four groups.
Conclusions The data suggest that magnesium infusion during a coronary occlusion has a significant benefit in reducing the IS in this model. Magnesium may have a beneficial clinical role in AMI, especially if administered before reperfusion as a bolus followed by a constant infusion.
Key Words: myocardial infarction • free radicals • infarction
This article has been cited by other articles:
 |
|
 |
|
  D. M. Yellon and D. J. Hausenloy Myocardial Reperfusion Injury N. Engl. J. Med., September 13, 2007; 357(11): 1121 - 1135. [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Dirksen, G. J. Laarman, M. L. Simoons, and D. J.G.M. Duncker Reperfusion injury in humans: A review of clinical trials on reperfusion injury inhibitory strategies Cardiovasc Res, June 1, 2007; 74(3): 343 - 355. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. B. Dobkowski Myocardial Protection During Minimally Invasive Cardiac Surgery Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2002; 6(4): 319 - 324. [Abstract] [PDF]
|
|
|
|
 |
|
 Q. Yang, Y.-C. Liu, W. Zou, A. P. C. Yim, and G.-W. He Protective effect of magnesium on the endothelial function mediated by endothelium-derived hyperpolarizing factor in coronary arteries during cardioplegic arrest in a porcine model J. Thorac. Cardiovasc. Surg., August 1, 2002; 124(2): 361 - 370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Matsusaka, N. Hasebe, Y.-T. Jin, J. Kawabe, and K. Kikuchi Magnesium reduces myocardial infarct size via enhancement of adenosine mechanism in rabbits Cardiovasc Res, June 1, 2002; 54(3): 568 - 575. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Woods Commentary: Biostatistics, biological mechanisms and Bayes: lessons from the magnesium trials Int. J. Epidemiol., February 1, 2002; 31(1): 105 - 106. [Full Text] [PDF]
|
|
|
|
 |
|
 V. Rukshin, B. Azarbal, P. K. Shah, V. T. Tsang, M. Shechter, A. Finkelstein, B. Cercek, and S. Kaul Intravenous Magnesium in Experimental Stent Thrombosis in Swine Arterioscler Thromb Vasc Biol, September 1, 2001; 21(9): 1544 - 1549. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. B. Ravn, U. Moeldrup, C. I. O. Brookes, L. B. Ilkjaer, P. White, M. Chew, L. Jensen, S. Johnsen, L. Birk-Soerensen, and V. E. Hjortdal Intravenous Magnesium Reduces Infarct Size After Ischemia/Reperfusion Injury Combined with a Thrombogenic Lesion in the Left Anterior Descending Artery Arterioscler Thromb Vasc Biol, March 1, 1999; 19(3): 569 - 574. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. B. Ravn, S. D. Kristensen, V. E. Hjortdal, K. Thygesen, and S. E.ær Husted Early Administration of Intravenous Magnesium Inhibits Arterial Thrombus Formation Arterioscler Thromb Vasc Biol, December 1, 1997; 17(12): 3620 - 3625. [Abstract] [Full Text]
|
|
|
|
|
|
C. H. Hennekens, C. M. Albert, S. L. Godfried, J. M. Gaziano, and J. E. Buring Adjunctive Drug Therapy of Acute Myocardial Infarction -- Evidence from Clinical Trials N. Engl. J. Med., November 28, 1996; 335(22): 1660 - 1668. [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Antman Magnesium in Acute MI : Timing Is Critical Circulation, November 1, 1995; 92(9): 2367 - 2372. [Full Text]
|
|
|
|
|
|
V. Rukshin, P. K. Shah, B. Cercek, A. Finkelstein, V. Tsang, and S. Kaul Comparative Antithrombotic Effects of Magnesium Sulfate and the Platelet Glycoprotein IIb/IIIa Inhibitors Tirofiban and Eptifibatide in a Canine Model of Stent Thrombosis Circulation, April 23, 2002; 105(16): 1970 - 1975. [Abstract] [Full Text] [PDF]
|
|